Advertisement

Topics

FDA gives breakthrough status, priority review to Erdheim-Chester drug

04:58 EDT 9 Aug 2017 | SmartBrief

A supplemental new drug application from Genentech for Zelboraf, or vemurafenib, received breakthrough designation and FDA pr -More

Original Article: FDA gives breakthrough status, priority review to Erdheim-Chester drug

NEXT ARTICLE

More From BioPortfolio on "FDA gives breakthrough status, priority review to Erdheim-Chester drug"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...